Cargando…
Mutacin H-29B is identical to mutacin II (J-T8)
BACKGROUND: Streptococcus mutans produces bacteriocins named mutacins. Studies of mutacins have always been hampered by the difficulties in obtaining active liquid preparations of these substances. Some of them were found to be lantibiotics, defined as bacterial ribosomally synthesised lanthionine-c...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462995/ https://www.ncbi.nlm.nih.gov/pubmed/16626493 http://dx.doi.org/10.1186/1471-2180-6-36 |
_version_ | 1782127522672017408 |
---|---|
author | Nicolas, Guillaume Morency, Hélène LaPointe, Gisèle Lavoie, Marc C |
author_facet | Nicolas, Guillaume Morency, Hélène LaPointe, Gisèle Lavoie, Marc C |
author_sort | Nicolas, Guillaume |
collection | PubMed |
description | BACKGROUND: Streptococcus mutans produces bacteriocins named mutacins. Studies of mutacins have always been hampered by the difficulties in obtaining active liquid preparations of these substances. Some of them were found to be lantibiotics, defined as bacterial ribosomally synthesised lanthionine-containing peptides with antimicrobial activity. The goal of this study was to produce and characterize a new mutacin from S. mutans strain 29B, as it shows a promising activity spectrum against current human pathogens. RESULTS: Mutacin H-29B, produced by S. mutans strain 29B, was purified by successive hydrophobic chromatography from a liquid preparation consisting of cheese whey permeate (6% w/v) supplemented with yeast extract (2%) and CaCO(3 )(1%). Edman degradation revealed 24 amino acids identical to those of mutacin II (also known as J-T8). The molecular mass of the purified peptide was evaluated at 3246.08 ± 0.1 Da by MALDI-TOF MS. CONCLUSION: A simple procedure for production and purification of mutacins along with its characterization is presented. Our results show that the amino acid sequence of mutacin H-29B is identical to the already known mutacin II (J-T8) over the first 24 residues. S. mutans strains of widely different origins may thus produce very similar bacteriocins. |
format | Text |
id | pubmed-1462995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-14629952006-05-18 Mutacin H-29B is identical to mutacin II (J-T8) Nicolas, Guillaume Morency, Hélène LaPointe, Gisèle Lavoie, Marc C BMC Microbiol Research Article BACKGROUND: Streptococcus mutans produces bacteriocins named mutacins. Studies of mutacins have always been hampered by the difficulties in obtaining active liquid preparations of these substances. Some of them were found to be lantibiotics, defined as bacterial ribosomally synthesised lanthionine-containing peptides with antimicrobial activity. The goal of this study was to produce and characterize a new mutacin from S. mutans strain 29B, as it shows a promising activity spectrum against current human pathogens. RESULTS: Mutacin H-29B, produced by S. mutans strain 29B, was purified by successive hydrophobic chromatography from a liquid preparation consisting of cheese whey permeate (6% w/v) supplemented with yeast extract (2%) and CaCO(3 )(1%). Edman degradation revealed 24 amino acids identical to those of mutacin II (also known as J-T8). The molecular mass of the purified peptide was evaluated at 3246.08 ± 0.1 Da by MALDI-TOF MS. CONCLUSION: A simple procedure for production and purification of mutacins along with its characterization is presented. Our results show that the amino acid sequence of mutacin H-29B is identical to the already known mutacin II (J-T8) over the first 24 residues. S. mutans strains of widely different origins may thus produce very similar bacteriocins. BioMed Central 2006-04-20 /pmc/articles/PMC1462995/ /pubmed/16626493 http://dx.doi.org/10.1186/1471-2180-6-36 Text en Copyright © 2006 Nicolas et al; licensee BioMed Central Ltd. |
spellingShingle | Research Article Nicolas, Guillaume Morency, Hélène LaPointe, Gisèle Lavoie, Marc C Mutacin H-29B is identical to mutacin II (J-T8) |
title | Mutacin H-29B is identical to mutacin II (J-T8) |
title_full | Mutacin H-29B is identical to mutacin II (J-T8) |
title_fullStr | Mutacin H-29B is identical to mutacin II (J-T8) |
title_full_unstemmed | Mutacin H-29B is identical to mutacin II (J-T8) |
title_short | Mutacin H-29B is identical to mutacin II (J-T8) |
title_sort | mutacin h-29b is identical to mutacin ii (j-t8) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462995/ https://www.ncbi.nlm.nih.gov/pubmed/16626493 http://dx.doi.org/10.1186/1471-2180-6-36 |
work_keys_str_mv | AT nicolasguillaume mutacinh29bisidenticaltomutaciniijt8 AT morencyhelene mutacinh29bisidenticaltomutaciniijt8 AT lapointegisele mutacinh29bisidenticaltomutaciniijt8 AT lavoiemarcc mutacinh29bisidenticaltomutaciniijt8 |